Brief: Initiator Pharma Performs Directed Issue, Suggests Fully-guaranteed Rights Issue

Initiator Pharma A/S

27/04/2020 07:37

April 27 (Reuters) - Initiator Pharma A/S  INIT.TE :
    * INITIATOR PHARMA A/S PERFORMS DIRECTED ISSUE AND SUGGESTS
FULLY
GUARANTEED RIGHTS ISSUE WITH THE AIM OF COMPLETING A PHASE IIA
CLINICAL TRIAL WITH IP2018
    * DIRECTED ISSUES ARE DIRECTED TO FORMUE NORD MARKEDSNEUTRAL
A/S
    * TO CARRY OUT A RIGHTS ISSUE OF UNITS OF INITIALLY
APPROXIMATELY
SEK 7 MILLION
    * DIRECTED SHARE ISSUE AND RIGHTS ISSUE THUS INITIALLY
PROVIDES
INITIATOR PHARMA A TOTAL OF ABOUT SEK 10 MILLION (BEFORE ISSUE
COSTS)
    * THROUGH ISSUES, WARRANTS ARE ISSUED WHICH DURING Q4 2020
CAN
PROVIDE INITIATOR PHARMA WITH A TOTAL OF APPROXIMATELY SEK 16.4
MILLION
    * HAS ENTERED INTO AN AGREEMENT ON A LOAN FACILITY THAT
GIVES
COMPANY RIGHT TO LEND UP TO SEK 10 MILLION, AS A SECURITY IF
WARRANTS ARE NOT EXERCISED
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE, WHICH AMOUNTS TO SEK
9.80
PER UNIT (CORRESPONDING TO SEK 4.90 PER SHARE)
    * SUBSCRIPTION PERIOD RUNS FROM JUNE 2, 2020 TO JUNE 16,
2020

Source text for Eikon:  ID:nWkr6xmcWq 
Further company coverage:  INIT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))